Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
The survival increase in Germany and the survival advantage in the USA might be explained by differences in incidence and stage distributions over time and across countries. Effects of early detection or a lead-time bias due to the more widespread utilisation and earlier introduction of PSA testing in the USA are likely to explain the observed patterns.
Our data indicate that short gestational age at birth in a range up to gestational week 37 is related to an increased risk of DCD.